2-(Dimethylamino)-1-(4-methylphenyl)-1-propanone | 1157738-08-3

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-(Dimethylamino)-1-(4-methylphenyl)-1-propanone
• 英文别名: 2-(dimethylamino)-1-(4-methylphenyl)propan-1-one
• CAS: 1157738-08-3
• 化学式: C₁₂H₁₇NO
• 分子量: 191.27
• InChiKey: FXLSIGLYVVJURY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• [EN] UROTENSIN II RECEPTOR MODULATORS<br/>[FR] MODULATEURS DU RECEPTEUR DE L'UROTENSINE II
  申请人：ACADIA PHARM INC

  公开号：WO2003104216A1

  公开（公告）日：2003-12-18

  Disclosed are compounds of Formula I, or salts or prodrugs thereof, complexed with a human urotensin II receptor as defined herein. Also disclosed are compounds of Formula II, or salts or prodrugs thereof, as defined herein. Also disclosed are methods of modulating the activity of a urotensin II receptor using a compound of Formula I, or a compound of Formula II, or salts or prodrugs thereof. In addition, methods of treating diseases related to the activity of urotensin II receptors are disclosed.

  本文披露了根据本文所定义的与人类尿嘧啶 II 受体形成络合物的 Formula I 化合物，或其盐或前药。还披露了根据本文所定义的 Formula II 化合物，或其盐或前药。还披露了使用 Formula I 化合物、Formula II 化合物、或其盐或前药来调节尿嘧啶 II 受体活性的方法。此外，还披露了治疗与尿嘧啶 II 受体活性相关疾病的方法。
• NOVEL TRIAZINE COMPOUNDS
  申请人：Sphaera Pharma Pte. Ltd.

  公开号：US20150197515A1

  公开（公告）日：2015-07-16

  The present invention relates to novel triazine compounds of formula (1). The present invention also discloses compounds of formula I along with other pharmaceutical acceptable excipients and use of the compounds to modulate the PI3K/mTOR pathway.

  本发明涉及一种新的三嗪化合物，其化学式为（1）。本发明还揭示了化学式I的化合物，以及其他药用可接受的辅料和使用这些化合物来调节PI3K/mTOR通路的方法。
• Urotensin II receptor agents
  申请人：——

  公开号：US20040077529A1

  公开（公告）日：2004-04-22

  Disclosed are compounds of Formula I, or salts or prodrugs thereof, complexed with a human urotensin II receptor 1 as defined herein. Also disclosed are compounds of Formula II, or salts or prodrugs thereof, 2 as defined herein. Also disclosed are methods of modulating the activity of a urotensin II receptor using a compound of Formula I, or a compound of Formula II, or salts or prodrugs thereof. In addition, methods of treating diseases related to the activity of urotensin II receptors are disclosed.
• CUCURBITURIL MOLECULAR CONTAINERS AND METHODS OF USING SAME
  申请人：University of Maryland, College Park

  公开号：US20210379099A1

  公开（公告）日：2021-12-09

  Disclosed herein are water-soluble, cyclic cucurbit[n]uril, compositions containing the same, methods of preparation thereof, and uses thereof. These compounds are useful, for example, as sequestering agents for various agents, such as, for example, drugs of abuse.
• US9630958B2
  申请人：——

  公开号：US9630958B2

  公开（公告）日：2017-04-25